Growing Number of Soft and Hard Tissue Augmentations Procedures of Acellular Dermal Matrices Market
The global acellular dermal matrices market is estimated to be valued at US$ 8.8 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Acellular dermal matrices offer many advantages to other skin substitutes. They provide an instantly available scaffold for cell and tissue ingrowth. Additionally, they integrate well with the host tissue. They also provide vascularization that leads to increased healing potential.
Weakness: Acellular dermal matrices are derived from human or animal tissues which carry risks of disease transmission or immune rejection. Additionally, these matrices are not a living substitute and cannot remodel or regenerate tissues on their own.
Opportunity: Rising incidence of skin defects and burns due to trauma, chronic wounds, and surgical procedures is driving the demand for effective dermal substitutes. Additionally, increasing research for developing acellular matrices that can promote regeneration is expected to provide growth opportunities.
Threats: Stringent regulatory policies governing dermal substitutes can increase costs of development and compliance. Additionally, lack of specialized professional skills for application and high costs of acellular matrices threaten their widespread adoption.
Key Takeaways
The Global Acellular Dermal Matrices Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The market size is estimated to reach US$ 8.8 Bn by 2024, and is expected to grow at a CAGR of 5.9% through 2030.
Regional analysis
North America dominates the global acellular dermal matrices market currently due to high adoption of advanced dermal substitutes and presence of major players in the region. The Asia Pacific region is expected to offer highest growth opportunities during the forecast period due to growing medical tourism, rising awareness, and increasing healthcare investments in the region.
Key players
Key players operating in the acellular dermal matrices market are Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc. These players are focusing on new product launches, geographic expansions and mergers & acquisitions to increase their market share.
Explore more information on this topic, Please visit –
https://www.ukwebwire.com/acellular-dermal-matrices-market-size-and-trends-analysis/
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian